Inventory / revenue moved 12620 bp lower
Inventory / revenue changed -12620 basis points from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory / revenue changed -12620 basis points from the comparable as-filed period.
Total assets changed -21.7% from the comparable as-filed period.
Current assets changed -21.3% from the comparable as-filed period.
Current ratio changed +382.2% from the comparable as-filed period.
R&D / revenue changed +1165 basis points from the comparable as-filed period.
Working capital / assets changed +30909 basis points from the comparable as-filed period.
Inventory changed -14.7% from the comparable as-filed period.
Gross profit changed +585.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Working capital changed +100.4% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Cost of revenue changed +3.5% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.